145 related articles for article (PubMed ID: 37104878)
1. Unradical Surgery for Locally-Advanced Thymoma: Is it time to evolve Perspectives?
Mastromarino MG; Bacchin D; Aprile V; Ceccarelli I; Korasidis S; Lenzini A; Ambrogi MC; Lucchi M
Lung Cancer; 2023 Jun; 180():107214. PubMed ID: 37104878
[TBL] [Abstract][Full Text] [Related]
2. Multimodality therapy for locally advanced thymomas: A propensity score-matched cohort study from the European Society of Thoracic Surgeons Database.
Leuzzi G; Rocco G; Ruffini E; Sperduti I; Detterbeck F; Weder W; Venuta F; Van Raemdonck D; Thomas P; Facciolo F;
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):47-57.e1. PubMed ID: 26403869
[TBL] [Abstract][Full Text] [Related]
3. Single-center evaluation of prognostic factors for thymoma treated by surgery: a retrospective study.
Kamata S; Ishida I; Suzuki Y; Oura H
J Cardiothorac Surg; 2021 Jan; 16(1):8. PubMed ID: 33413522
[TBL] [Abstract][Full Text] [Related]
4. Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience.
Ruffini E; Filosso PL; Mossetti C; Bruna MC; Novero D; Lista P; Casadio C; Oliaro A
Eur J Cardiothorac Surg; 2011 Jul; 40(1):146-53. PubMed ID: 21093283
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival in advanced thymomas: The role of the number of involved structures.
Chiappetta M; Aprile V; Lococo F; Zanfrini E; Nachira D; Meacci E; Korasidis S; Ambrogi M; Lucchi M; Margaritora S
J Surg Oncol; 2021 Oct; 124(5):858-866. PubMed ID: 34252198
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of recurrent thymoma: is it worthwhile?†.
Marulli G; Margaritora S; Lucchi M; Cardillo G; Granone P; Mussi A; Carleo F; Perissinotto E; Rea F
Eur J Cardiothorac Surg; 2016 Jan; 49(1):327-32. PubMed ID: 25755187
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted magnetic resonance imaging of thymoma: ability of the Apparent Diffusion Coefficient in predicting the World Health Organization (WHO) classification and the Masaoka-Koga staging system and its prognostic significance on disease-free survival.
Priola AM; Priola SM; Giraudo MT; Gned D; Fornari A; Ferrero B; Ducco L; Veltri A
Eur Radiol; 2016 Jul; 26(7):2126-38. PubMed ID: 26427698
[TBL] [Abstract][Full Text] [Related]
8. Outcome of multimodality treatment for 188 cases of type B3 thymoma.
Gao L; Wang C; Fang W; Zhang J; Lv C; Fu S
J Thorac Oncol; 2013 Oct; 8(10):1329-34. PubMed ID: 24457243
[TBL] [Abstract][Full Text] [Related]
9. Pathologic radioresponse of preoperatively irradiated invasive thymomas.
Onuki T; Ishikawa S; Yamamoto T; Ito H; Sakai M; Onizuka M; Sakakibara Y; Iijima T; Noguchi M; Ohara K
J Thorac Oncol; 2008 Mar; 3(3):270-6. PubMed ID: 18317070
[TBL] [Abstract][Full Text] [Related]
10. Thymoma patients with pleural dissemination: nationwide retrospective study of 136 cases in Japan.
Okuda K; Yano M; Yoshino I; Okumura M; Higashiyama M; Suzuki K; Tsuchida M; Usuda J; Tateyama H
Ann Thorac Surg; 2014 May; 97(5):1743-8. PubMed ID: 24657034
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Correlation between Tumor Volume and Complete Resection of Thymoma at Different Masaoka-Koga Stages.
Yuan HZ; Zhao L; Tao YL; Ding JY; Chen G
Discov Med; 2023 Apr; 35(175):178-184. PubMed ID: 37105927
[TBL] [Abstract][Full Text] [Related]
12. Multimodality treatments in locally advanced stage thymomas.
Hassan M; Seoud DE
Hematol Oncol Stem Cell Ther; 2009; 2(2):340-4. PubMed ID: 20118057
[TBL] [Abstract][Full Text] [Related]
13. Thymoma: prognostic factors and treatment outcomes.
Gripp S; Hilgers K; Wurm R; Schmitt G
Cancer; 1998 Oct; 83(8):1495-503. PubMed ID: 9781943
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.
Kim ES; Putnam JB; Komaki R; Walsh GL; Ro JY; Shin HJ; Truong M; Moon H; Swisher SG; Fossella FV; Khuri FR; Hong WK; Shin DM
Lung Cancer; 2004 Jun; 44(3):369-79. PubMed ID: 15140551
[TBL] [Abstract][Full Text] [Related]
15. Tumor location may affect the clinicopathological features and prognosis of thymomas.
Tian D; Shiiya H; Sato M; Sun CB; Anraku M; Nakajima J
Thorac Cancer; 2019 Nov; 10(11):2096-2105. PubMed ID: 31499597
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up.
Lucchi M; Melfi F; Dini P; Basolo F; Viti A; Givigliano F; Angeletti CA; Mussi A
J Thorac Oncol; 2006 May; 1(4):308-13. PubMed ID: 17409875
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary treatment of malignant thymoma.
Spaggiari L; Casiraghi M; Guarize J
Curr Opin Oncol; 2012 Mar; 24(2):117-22. PubMed ID: 22143371
[TBL] [Abstract][Full Text] [Related]
18. Comparison of oncological results for early- and advanced-stage thymomas: thoracoscopic thymectomy versus open thymectomy.
Odaka M; Shibasaki T; Kato D; Mori S; Asano H; Yamashita M; Morikawa T
Surg Endosc; 2017 Feb; 31(2):734-742. PubMed ID: 27324338
[TBL] [Abstract][Full Text] [Related]
19. Impact of Definitive Radiotherapy and Surgical Debulking on Treatment Outcome and Prognosis for Locally Advanced Masaoka-Koga stage III Thymoma.
Fan C; Ge H; Zhang S; Xing W; Ye K; Zheng Y; Sun H; Wang H; Zheng X; Zhang R; Liu M
Sci Rep; 2020 Feb; 10(1):1735. PubMed ID: 32015469
[TBL] [Abstract][Full Text] [Related]
20. Oncological outcomes of thoracoscopic thymectomy for the treatment of stages I-III thymomas.
Odaka M; Akiba T; Mori S; Asano H; Marushima H; Yamashita M; Kamiya N; Morikawa T
Interact Cardiovasc Thorac Surg; 2013 Aug; 17(2):285-90. PubMed ID: 23633558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
